Investments

Clinical Candidates

Over ten GHIT development partnerships have conducted clinical programs worldwide.
Please see each program to know more details.

Tuberculosis / Diagnostics
Lung Flute ECO
1. - Development Stage: Product Validation
  - Country: Cameroon
Details
Malaria / Vaccine
AnAPN1
1. - Development Stage: Phase I Clinical Trial
  - Country: Gabon (Planned)
Photo credit: Biopromic AB
Details
Mycetoma / Drug
Fosravuconazole
1. - Development Stage: Phase III Clinical Trial
  - Country: Sudan
© Purushottam Diwakar-DNDi
Details
Cutaneous leishmaniasis / Drug
CpG-D35
1. - Development Stage: Phase I Clinical Trial
  - Country: United Kingdom, Colombia
© Sydelle Willow Smith-DNDi
Details
Lymphatic filariasis, Onchocerciasis / Drug
AWZ1066S
1. - Development Stage: Phase I Clinical Trial
  - Country: United Kingdom, Cameroon (planned)
Photo credit: Kate Dodd
Details
Buruli Ulcer / Diagnostics
BU-MYCOLAC
1. - Development Stage: Product Development
  - Country: Cameroon, Ivory Coast
Photo credit: FIND
Details
Chagas disease / Diagnostics
Chagas-LAMP
1. - Development Stage: Product Validation
  - Country: Argentina, Bolivia, Paraguay
Photo credit: CONICET-INGEBI
Details
Leishmaniasis / Diagnostics
Leishmania Skin Test (LST)
1. - Development Stage: Product Development
  - Country: India and Africa (Planned)
Details
Schistosomiasis / Diagnostics
SCH CAA RDT
1. - Development Stage: Product Development
  - Country: Kenya, Philippines
Photo credit: Vinicius Berger-DNDi
Details
Schistosomiasis / Pediatric Drug
Arpraziquantel
1. - Development Stage: Registration, Access
  - Country: Ivory Coast, Kenya, Uganda and other endemic countries.
Photo credit: SCI Foundation/Uganda
Details